Press "Enter" to skip to content

Conservative Momentum Builds to Stop Big Government, Big Pharma Attack on Americans’ Pharmacy Benefits

By CONSERVATIVES FOR LOWER HEALTH CARE COSTS (SPONSORED)

 

The following content is sponsored by Conservatives for Lower Health Care Costs.

Recently, Big Pharma and Big Government have teamed up in a full-blown attack against free market solutions in the prescription drug market by focusing on Pharmacy Benefit Managers (PBMs) – which currently serve as the only real check on big pharmaceutical companies’ ability to set sky-high prices for prescription drugs.

Policies targeting PBMs would undermine America’s core free market values and deliver Big Pharma a major financial windfall at the expense of American patients, taxpayers, and business owners.

For example, the latest proposal – known as “delinking” – would eliminate market-based incentives for PBMs to secure higher rebates when negotiating with big pharmaceutical companies. The result would be higher health care costs for patients, taxpayers, and businesses, reduced freedoms for employers to design their own benefits, and a $32 billion bailout for Big Pharma.

Politicians like Sen. Bernie Sanders (I-VE) have revealed the long-term design of these proposals: bringing our country one large step closer to a fully nationalized, government-run health care system. Earlier this year, New York Democrat Rep. Alexandria Ocasio Cortez (AOC) cited proposals targeting PBMs as “Just one example of why Medicare for All is so essential.”

In response, conservatives across the nation are sounding the alarm on how these measures would be disastrous for hardworking American families and small businesses, explaining how anti-PBM policies would take critical savings out of their pockets and hand them to Big Pharma in the form of higher profits.

U.S. Senator Rand Paul (R-KY), aired his concerns about policies undermining free market forces by targeting PBMs:

Like so many misguided policies in Washington, this bill may actually raise drug prices. If that happens, just imagine the outcry for a single-payer health care system with government price controls. Maybe that’s exactly what the left is betting on—that if drug companies have free rein, the American people will get fed up fast, and demand a socialist paradise. Let’s hope they don’t get their wish.

Other leading conservatives like former Sen. Pat Toomey (R-PA) have warned against harmful government interference in the free market, detailing how PBMs help promote free market principles and exist as a check on Big Pharma’s seemingly unlimited monopolistic power:

If you are a consumer, if you have a health insurance plan, if you have prescription drug coverage with your plan, then chances are very good that you’re paying less for prescription drugs than you otherwise would because there’s a PBM involved that’s negotiating those lower prices. For Congress to come in and say, “Oh, we’re going to disrupt this. And we’re going to disrupt it by making it much more difficult for one of the players in this supply chain to operate” I think that’s a big mistake…

READ FULL ARTICLE HERE... (breitbart.com)Live Stream + Chat (zutalk.com)

 


Home | Caravan to Midnight (zutalk.com)

We Need Your Help To Keep Caravan To Midnight Going,

Please Consider Donating To Help Keep Independent Media Independent

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Breaking News: